← Back to grants
Grant✓ Small businesses may apply

Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)

National Institutes of Health

Program funding

$4,520,000

Opportunity #
RFA-AI-27-004
Agency
National Institutes of Health
ALN (CFDA)
93.855
Status
posted
Posted
Jun 29, 2026
Closes
Sep 24, 2026
Funding instrument
Cooperative Agreement
Category
Health
Cost sharing required
No

Who can apply

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Synopsis

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.

Contact

National Institutes of Health · minnicozzim@niaid.nih.gov

View full notice on Grants.gov ↗